MDM2 and hepatocellular carcinoma: Mechanistically, our previous research on pancreatic cancer (Wang et al., 2018) and hepatocellular carcinoma (HCC) (Wang et al., 2019c) demonstrated that MA242 destabilizes the MDM2 protein by shortening its half-life and promoting its degradation through the proteasome.